1,7-phenanthroline has been researched along with Leukemia P388 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fisher, JM; Mohindru, A; Rabinovitz, M | 1 |
Li, ZT; Ma, GE; Yang, BJ | 1 |
Chitnis, MP; Mital, R; Parekh, HK; Srivastava, TS | 1 |
3 other study(ies) available for 1,7-phenanthroline and Leukemia P388
Article | Year |
---|---|
2,9-Dimethyl-1,10-phenanthroline (neocuproine): a potent, copper-dependent cytotoxin with anti-tumor activity.
Topics: Animals; Antineoplastic Agents; Biological Transport; Cell Line; Cell Survival; Copper; Leukemia L1210; Leukemia P388; Male; Mice; Phenanthrolines | 1983 |
[Chemical studies of Salvia miltiorrhiza f. alba].
Topics: Animals; Drugs, Chinese Herbal; Leukemia P388; Mice; Phenanthrolines; Tumor Cells, Cultured | 1991 |
Synthesis, characterization, DNA binding, and cytotoxic studies of some mixed-ligand palladium(II) and platinum(II) complexes of alpha-diimine and amino acids.
Topics: Amino Acids; Animals; Antineoplastic Agents; Cisplatin; DNA; Ethidium; Glycine; Hydrogen Bonding; Leukemia P388; Magnetic Resonance Spectroscopy; Molecular Structure; Organometallic Compounds; Palladium; Phenanthrolines; Spectrometry, Fluorescence; Spectrophotometry; Valine | 1991 |